Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 2Phase 4 1

Status

Completed 50Active not recruiting 10Unknown 9Terminated 9Recruiting 6Not yet recruiting 1

Sponsor Class

OTHER 5INDUSTRY 1

Study Type

Interventional 6

Sponsor

Cancer Type

Lymphoid 6

Conditions

Lymphoma, Large B-Cell, Diffuse 18Sarcoma 15Burkitt Lymphoma 9Breast Neoplasms 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Neoplasm Metastasis 8Triple Negative Breast Neoplasms 7Lymphoma, T-Cell, Peripheral 7Lymphoma, Follicular 7Lymphoma, B-Cell 7Ovarian Neoplasms 6Lymphoma 6Hodgkin Disease 6Endometrial Neoplasms 5Osteosarcoma 4Neuroblastoma 4Lymphoma, Non-Hodgkin 4Liposarcoma 4Recurrence 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Peritoneal Neoplasms 3Neoplasms 3Leukemia, Biphenotypic, Acute 3Leiomyosarcoma 3Histiocytoma, Malignant Fibrous 3Hemangiosarcoma 3Colorectal Neoplasms 3Uterine Neoplasms 2Stomach Neoplasms 2Sarcoma, Synovial 2

Interventions

Cyclophosphamide 13pembrolizumab 8Brentuximab Vedotin 8fludarabine 7Nivolumab 7Whole-Body Irradiation 6Specimen Handling 6Mycophenolic Acid 6Gemcitabine 6Etoposide 6Doxorubicin 6Dacarbazine 6fludarabine phosphate 5Vinblastine 5Melphalan 5Granulocyte Colony-Stimulating Factor 5Filgrastim 5Dexamethasone 5Stem Cell Transplantation 4Cytarabine 4Vinorelbine 3Tacrolimus 3Magnetic Resonance Spectroscopy 3Cyclosporine 3Carmustine 3Blood Specimen Collection 3thymoglobulin 2polatuzumab vedotin 2pegylated granulocyte colony-stimulating factor 2pegfilgrastim 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Recruiting × Hodgkin Disease × Doxorubicin × Clear all
NCT04685616 2026-06-02

RADAR

University College, London

Phase 3 Recruiting
1,042 enrolled
Lymphoid

Hodgkin Disease

NCT06377566 2026-04-23

A Study of BV-AVD in People With Bulky Hodgkin Lymphoma

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
71 enrolled
Lymphoid

Hodgkin Disease

NCT06831370 2026-02-23

A Study of Brentuximab Vedotin With Doxorubicin, Vinblastine and Dacarbazine in Adults With Hodgkin Lymphoma in India

Takeda

Phase 4 Recruiting
124 enrolled
Lymphoid

Hodgkin Disease, Lymphoma

NCT06984146 2025-11-26

Nivo40-AVD for Advanced Classic Hodgkin Lymphoma

National Medical Research Radiological Centre of the Ministry of Health of Russia

Phase 2 Recruiting
54 enrolled
Lymphoid

Hodgkin Disease

NCT07002216 2025-11-03

BrECADD

University of Miami

Phase 2 Recruiting
48 enrolled
Lymphoid

Hodgkin Disease

NCT04638790 2024-09-27

HL-Russia-1

State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia

Phase 3 Recruiting
300 enrolled
Lymphoid

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡